Immune-related adverse events as a biomarker in non-melanoma patients treated with programmed cell death 1 inhibitors

Julia Judd, Matthew Zibelman, Elizabeth Handorf, John O’Neill, Chethan Ramamurthy, Sasini Bentota, Jamie Doyle, Robert G. Uzzo, Jessica Bauman, Hossein Borghaei, Elizabeth R. Plimack, Ranee Mehra, Daniel M. Geynisman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Immune-related adverse events as a biomarker in non-melanoma patients treated with programmed cell death 1 inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences